Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» drug pricing
drug pricing
PBM trade group ad campaign hits back at drugmakers over prescription drug prices
PBM trade group ad campaign hits back at drugmakers over prescription drug prices
Medical Marketing and Media
PhRMA
PBMs
drug pricing
Flag link:
‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
Stat
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
patients
Flag link:
CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies
CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies
American Journal of Managed Care
drug pricing
CMS
Medicare
Medicaid
accelerated approval
Flag link:
Centene agrees to $215 million settlement with California for alleged Medicaid overfilling
Centene agrees to $215 million settlement with California for alleged Medicaid overfilling
Medical Marketing and Media
Centene
California
Medicaid
drug pricing
legal
Flag link:
Medicare announces plan to recoup billions from drug companies
Medicare announces plan to recoup billions from drug companies
NPR
Medicare
drug pricing
Inflation Reduction Act
Flag link:
In State of the Union, Biden highlights drug prices, cancer, and affordable care
In State of the Union, Biden highlights drug prices, cancer, and affordable care
Chief Healthcare Executive
Joe Biden
drug pricing
healthcare reform
cancer
Flag link:
The Senate's bipartisan drug price push
The Senate's bipartisan drug price push
Axios
Senate
legislation
drug pricing
Flag link:
Biden to push for universal insulin price cap in State of the Union
Biden to push for universal insulin price cap in State of the Union
Politico
Joe Biden
drug pricing
insulin
diabetes
Flag link:
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics
Fierce Pharma
Vertex Pharmaceuticals
drug pricing
activists
Trikafta
cystic fibrosis
Flag link:
Inside pharma’s push to amend new drug-pricing law
Inside pharma’s push to amend new drug-pricing law
Medical Marketing and Media
drug pricing
Inflation Reduction Act
Flag link:
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Amgen
Amjevita
AbbVie
Humira
biosimilars
drug pricing
Flag link:
PBMs likely to be a focus in 118th Congress
PBMs likely to be a focus in 118th Congress
Roll Call
PBMs
congress
drug pricing
Flag link:
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Fierce Pharma
Moderna Therapeutics
drug pricing
vaccines
COVID-19
Senate
Flag link:
AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out
AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out
Fierce Pharma
AbbVie
Novartis
China
drug pricing
Pfizer
Paxlovid
Flag link:
AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
ABPI
AbbVie
Eli Lilly
UK
NHS
drug pricing
Flag link:
California is latest state to sue drug companies over high insulin prices
California is latest state to sue drug companies over high insulin prices
Marketwatch
California
drug pricing
insulin
diabetes
legal
Flag link:
Eisai learns from Biogen’s Aduhelm disaster
Eisai learns from Biogen’s Aduhelm disaster
EP Vantage
Eisai
Biogen
Leqembi
Aduhelm
Alzheimer's disease
drug pricing
Flag link:
Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy
Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy
BioPharma Dive
Eisai
Biogen
drug pricing
Leqembi
Alzheimer's disease
lecanemab
Flag link:
Pharma companies boost drug prices to start year, but hikes lag inflation
Pharma companies boost drug prices to start year, but hikes lag inflation
BioPharma Dive
drug pricing
Flag link:
Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing
Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing
Forbes
Mark Cuban
generics
drug pricing
Mark Cuban Cost Plus Drugs
Flag link:
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »